PEDIATRICS Vol. 47 No. 5 May 1971, pp. 913-915
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, A. E.
Right arrow Articles by Tanindi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, A. E.
Right arrow Articles by Tanindi, S.

The LaBrosse Spot Test: A Practical Aid in the Diagnosis and Management of Children with Neuroblastoma

Audrey E. Evans M.D.1, Judith Blore B.A.1, Richard Hadley M.D.1, and Sakir Tanindi M.D.1

1 The Children's Hospital of Philadelphia, 1740 Bainbridge Street, Philadelphia, Pennsylvania 19146

Measurement of vanillylmandelic acid (4-hydroxy-3 methoxy-mandelic acid or VMA) in the urine of patients with neuroblastoma has become part of the routine work up, since its presence was described by Voorhess and Gardner in 1960.1 When quantitative measurements of this catecholamine metabolite are performed, the patient must be placed on a strict diet for 2 to 3 days to eliminate substances whose breakdown products appear in the urine and give false positive results. The numerous items which must be excluded are beverages such as tea, colas, and Kcol-Aid, desserts and pastries flavored with chocolate and vanilla, and a variety of fruits including oranges, bananas, grapes, and tomatoes.